Identification of CD19 as a shared biomarker via PPARγ/β-catenin/Wnt3a pathway linking psoriasis and major depressive disorder
CD19 may serve as a common biomarker or therapeutic target of psoriasis and MDD via PPARγ/β-catenin/Wnt3a pathway.
Authors
- Bin Zhou (ORCID: https://orcid.org/0000-0002-5486-2285)
- Jiahao Yang (ORCID: https://orcid.org/0000-0002-1283-3929)
- Changzheng Huang (ORCID: https://orcid.org/0000-0003-1531-1269)
- Haitao Li (ORCID: https://orcid.org/0000-0001-6741-293X)
- Ting Wu (ORCID: https://orcid.org/0000-0003-2886-9202)
- Zhujun Ma
- Hanying Ma (ORCID: https://orcid.org/0009-0009-3526-0527)
- Yunli Ling
Institutions
- Huanggang Normal University (CN)
- Union Hospital (HK)
- Nanchang University (CN)
- Second Affiliated Hospital of Nanchang University (CN)
- Wuhan Union Hospital (CN)
- Beijing YouAn Hospital (CN)
- Yichang Central People's Hospital (CN)
- Union Hospital (CN)
- Huazhong University of Science and Technology (CN)
Publication Details
- Journal
- Journal of Affective Disorders
- Published
- 2024-08-26
- DOI
- https://doi.org/10.1016/j.jad.2024.08.159
- Citations
- 5
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.63
Funders
- National Natural Science Foundation of China
- Huazhong University of Science and Technology